|
1
|
Gratwohl A, Baldomero H, Gratwohl M,
Aljurf M, Bouzas LF, Horowitz M, Kodera Y, Lipton J, Iida M,
Pasquini MC, et al: Quantitative and qualitative differences in use
and trends of hematopoietic stem cell transplantation: A Global
Observational Study. Haematologica. 98:1282–1290. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Passweg JR, Baldomero H, Gratwohl A,
Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B,
Marsh J, et al: The EBMT activity survey: 1990–2010. Bone Marrow
Transplant. 47:906–923. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oshrine BR, Olson TS and Bunin N: Mixed
chimerism and graft loss in pediatric recipients of an
alemtuzumab-based reduced-intensity conditioning regimen for
non-malignant disease. Pediatr Blood Cancer. 61:1852–1859. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lawler M, McCann SR, Marsh JC, Ljungman P,
Hows J, Vandenberghe E, O'Riordan J, Locasciulli A, Socié G, Kelly
A, et al: Serial chimerism analyses indicate that mixed
haemopoietic chimerism influences the probability of graft
rejection and disease recurrence following allogeneic stem cell
transplantation (SCT) for severe aplastic anaemia (SAA): Indication
for routine assessment of chimerism post SCT for SAA. Br J
Haematol. 144:933–945. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Terwey TH, Hemmati PG, Nagy M, Pfeifer H,
Gökbuget N, Brüggemann M, Le Duc TM, le Coutre P, Dörken B and
Arnold R: Comparison of chimerism and minimal residual disease
monitoring for relapse prediction after allogeneic stem cell
transplantation for adult acute lymphoblastic leukemia. Biol Blood
Marrow Transplant. 20:1522–1529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clark JR, Scott SD, Jack AL, Lee H, Mason
J, Carter GI, Pearce L, Jackson T, Clouston H, Sproul A, et al:
Monitoring of chimerism following allogeneic haematopoietic stem
cell transplantation (HSCT): Technical recommendations for the use
of short tandem repeat (STR) based techniques, on behalf of the
United Kingdom national external quality assessment service for
leucocyte immunophenotyping chimerism working group. Br J Haematol.
168:26–37. 2015. View Article : Google Scholar
|
|
7
|
Bader P, Kreyenberg H, Hoelle W, Dueckers
G, Handgretinger R, Lang P, Kremens B, Dilloo D, Sykora KW,
Schrappe M, et al: Increasing mixed chimerism is an important
prognostic factor for unfavorable outcome in children with acute
lymphoblastic leukemia after allogeneic stem-cell transplantation:
Possible role for pre-emptive immunotherapy? J Clin Oncol.
22:1696–1705. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gineikiene E, Stoskus M and Griskevicius
L: Single nucleotide polymorphism-based system improves the
applicability of quantitative PCR for chimerism monitoring. J Mol
Diagn. 11:66–74. 2009. View Article : Google Scholar :
|
|
9
|
Lion T, Watzinger F, Preuner S, Kreyenberg
H, Tilanus M, de Weger R, van Loon J, de Vries L, Cavé H, Acquaviva
C, et al: The EuroChimerism concept for a standardized approach to
chimerism analysis after allogeneic stem cell transplantation.
Leukemia. 26:1821–1828. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pareek CS, Smoczynski R and Tretyn A:
Sequencing technologies and genome sequencing. J Appl Genet.
52:413–435. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xuan J, Yu Y, Qing T, Guo L and Shi L:
Next-generation sequencing in the clinic: Promises and challenges.
Cancer Lett. 340:284–295. 2013. View Article : Google Scholar
|
|
12
|
Ladetto M, Brüggemann M, Monitillo L,
Ferrero S, Pepin F, Drandi D, Barbero D, Palumbo A, Passera R,
Boccadoro M, et al: Next-generation sequencing and real-time
quantitative PCR for minimal residual disease detection in B-cell
disorders. Leukemia. 28:1299–1307. 2014. View Article : Google Scholar
|
|
13
|
Lawrence M, Huber W, Pagès H, Aboyoun P,
Carlson M, Gentleman R, Morgan MT and Carey VJ: Software for
computing and annotating genomic ranges. PLoS Comput Biol.
9:e10031182013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bai L, Deng YM, Dodds AJ, Milliken S,
Moore J and Ma DD: A SYBR green-based real-time PCR method for
detection of haemopoietic chimerism in allogeneic haemopoietic stem
cell transplant recipients. Eur J Haematol. 77:425–431. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mwaigwisya S, Assiri RA and O'Grady J:
Emerging commercial molecular tests for the diagnosis of
bloodstream infection. Expert Rev Mol Diagn. 15:681–692. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
D'Argenio V, Esposito MV, Telese A,
Precone V, Starnone F, Nunziato M, Cantiello P, Iorio M,
Evangelista E, D'Aiuto M, et al: The molecular analysis of BRCA1
and BRCA2: Next-generation sequencing supersedes conventional
approaches. Clin Chim Acta. 446:221–225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Børsting C and Morling N: Next generation
sequencing and its applications in forensic genetics. Forensic Sci
Int Genet. 18:78–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Debeljak M, Freed DN, Welch AJ, Haley L,
Beierl K, Iglehart BS, Pallavajjala A, Gocke CD, Leffell MS, Lin
MT, et al: Haplotype counting by next-generation sequencing for
ultrasensitive human DNA detection. J Mol Diagn. 16:495–503. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim J, Hwang IS, Kim HS, Joo DJ, Hong KR
and Choi JR: Bone marrow chimerism detection using next generation
sequencing based on single nucleotide polymorphisms following liver
transplantation: Comparison with short tandem repeat-PCR. Ann Lab
Med. 36:82–84. 2016. View Article : Google Scholar :
|
|
20
|
Chen DP, Tsai SH, Tseng CP, Wu TL, Chang
PY and Sun CF: Bone marrow transplant relapse with loss of an
allele. Clin Chim Acta. 387:161–164. 2008. View Article : Google Scholar
|
|
21
|
Bragg LM, Stone G, Butler MK, Hugenholtz P
and Tyson GW: Shining a light on dark sequencing: Characterizing
errors in Ion Torrent PGM data. PLoS Comput Biol. 9:e10030312013.
View Article : Google Scholar
|
